Phinomics

Phinomics is a Silicon Valley-based biotechnology company that decodes the hidden biology of cancer to power the next generation of precision therapeutics and diagnostics. Spun out of Stanford University from the laboratory of Nobel laureate Andrew Fire, the company has developed a proprietary "Deep Biology" platform centered on the "Circulome"—the complete repertoire of extrachromosomal circular DNA (eccDNA), which is a key driver of oncogenesis and drug resistance. By capturing eccDNA at 100x higher resolution than conventional sequencing and integrating it with genomic, transcriptomic, epigenomic, and proteomic data from matched patient samples, Phinomics uses explainable AI to identify novel therapeutic targets, resistance pathways, and patient-stratification biomarkers. The company is headquartered in San Carlos, California, with a European hub at Bayer Co.Lab in Berlin, Germany.